COMLEX LEVEL 2 Arc Deck 12
2026 Exam All Answers and
Illustrations Given
if you do not have a positive surface antigen are you still infected or are you
considered recovered? - 🧠 ANSWER ✔✔recovered
in the pump handle ribs there is narrowing of the intercoastal space below
the dysfunction anteriorly what is the dysfunction? - 🧠 ANSWER
✔✔exhaled dysfunction
,what is the treatment for a phyllodes tumor? - 🧠 ANSWER ✔✔Wide local
excision, rarely mastectomy. No axillary node dissection necessary (spread
is hematogenous, not lymphatic)
kerincterus - 🧠 ANSWER ✔✔Unconjugated bilirubin deposited in the brain
what study should be used to determine prevalence? - 🧠 ANSWER
✔✔cross-sectional study
what study is used to determine incidence? - 🧠 ANSWER ✔✔cohort study
what study is used to determine risk - 🧠 ANSWER ✔✔cohort study
what study is used to determine odds ratio - 🧠 ANSWER ✔✔case control
when is acyclovir started for pregnant women? - 🧠 ANSWER ✔✔week 36
teriparatide - 🧠 ANSWER ✔✔MOA: recombinant PTH analog given subQ, ↑
osteoblastic activity
Clinical use: osteoporosis, causes ↑ bone growth compared to
antiresorptive therapies (e.g., bisphosphonates)
,Toxicity: transient hypercalcemia
what is 1st line treatment for paget disease of the bone - 🧠 ANSWER
✔✔bisphosphonate
What is relapsing polychondritis? - 🧠 ANSWER ✔✔It is a rheumatologic
disorder characterized by immunomodulated cartilaginous inflammation.
What age group typically presents with relapsing polychondritis? - 🧠
ANSWER ✔✔Patients in their 40s to 60s.
Which HLA type is strongly associated with relapsing polychondritis? - 🧠
ANSWER ✔✔HLA-DR4.
In which areas of the body does relapsing polychondritis typically present?
- 🧠 ANSWER ✔✔Ears, nose, laryngotracheobronchial tree, eyes, and
joints.
What are some potential complications of relapsing polychondritis? - 🧠
ANSWER ✔✔Neurosensory hearing loss, cardiac disease, and renal
disease.
What physical deformity can result from relapsing polychondritis? - 🧠
ANSWER ✔✔Saddle nose deformity.
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, case control study - 🧠 ANSWER ✔✔A type of epidemiologic study where a
group of individuals with the diseases, referred to as cases, are compared
to individuals without the disease, referred to as controls
phase 3 clinical trial - 🧠 ANSWER ✔✔The final phase in clinical trials where
the drug is tested to observe its effects in a much larger group of patients.
goal is to determine a drug's therapeutic effect in this stage it is presumed
that the drug would have an effect
phase 1 clinical trial - 🧠 ANSWER ✔✔determines whether drug is safe for
efficacy
in this phase drug is not presumed to have any therapeutic effect
what clinical phase is performed in vitro and in vivo animal studies - 🧠
ANSWER ✔✔preclinical
phase 2 clinical study - 🧠 ANSWER ✔✔goal is determine if drug can have
any efficacy
2026 Exam All Answers and
Illustrations Given
if you do not have a positive surface antigen are you still infected or are you
considered recovered? - 🧠 ANSWER ✔✔recovered
in the pump handle ribs there is narrowing of the intercoastal space below
the dysfunction anteriorly what is the dysfunction? - 🧠 ANSWER
✔✔exhaled dysfunction
,what is the treatment for a phyllodes tumor? - 🧠 ANSWER ✔✔Wide local
excision, rarely mastectomy. No axillary node dissection necessary (spread
is hematogenous, not lymphatic)
kerincterus - 🧠 ANSWER ✔✔Unconjugated bilirubin deposited in the brain
what study should be used to determine prevalence? - 🧠 ANSWER
✔✔cross-sectional study
what study is used to determine incidence? - 🧠 ANSWER ✔✔cohort study
what study is used to determine risk - 🧠 ANSWER ✔✔cohort study
what study is used to determine odds ratio - 🧠 ANSWER ✔✔case control
when is acyclovir started for pregnant women? - 🧠 ANSWER ✔✔week 36
teriparatide - 🧠 ANSWER ✔✔MOA: recombinant PTH analog given subQ, ↑
osteoblastic activity
Clinical use: osteoporosis, causes ↑ bone growth compared to
antiresorptive therapies (e.g., bisphosphonates)
,Toxicity: transient hypercalcemia
what is 1st line treatment for paget disease of the bone - 🧠 ANSWER
✔✔bisphosphonate
What is relapsing polychondritis? - 🧠 ANSWER ✔✔It is a rheumatologic
disorder characterized by immunomodulated cartilaginous inflammation.
What age group typically presents with relapsing polychondritis? - 🧠
ANSWER ✔✔Patients in their 40s to 60s.
Which HLA type is strongly associated with relapsing polychondritis? - 🧠
ANSWER ✔✔HLA-DR4.
In which areas of the body does relapsing polychondritis typically present?
- 🧠 ANSWER ✔✔Ears, nose, laryngotracheobronchial tree, eyes, and
joints.
What are some potential complications of relapsing polychondritis? - 🧠
ANSWER ✔✔Neurosensory hearing loss, cardiac disease, and renal
disease.
What physical deformity can result from relapsing polychondritis? - 🧠
ANSWER ✔✔Saddle nose deformity.
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, case control study - 🧠 ANSWER ✔✔A type of epidemiologic study where a
group of individuals with the diseases, referred to as cases, are compared
to individuals without the disease, referred to as controls
phase 3 clinical trial - 🧠 ANSWER ✔✔The final phase in clinical trials where
the drug is tested to observe its effects in a much larger group of patients.
goal is to determine a drug's therapeutic effect in this stage it is presumed
that the drug would have an effect
phase 1 clinical trial - 🧠 ANSWER ✔✔determines whether drug is safe for
efficacy
in this phase drug is not presumed to have any therapeutic effect
what clinical phase is performed in vitro and in vivo animal studies - 🧠
ANSWER ✔✔preclinical
phase 2 clinical study - 🧠 ANSWER ✔✔goal is determine if drug can have
any efficacy
